List of Excipients in API methoxsalen
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing methoxsalen
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Bausch Health US LLC | OXSORALEN-ULTRA | methoxsalen | 0187-0650 | 1,4-SORBITAN | |
| Bausch Health US LLC | OXSORALEN-ULTRA | methoxsalen | 0187-0650 | D&C YELLOW NO. 10 | |
| Bausch Health US LLC | OXSORALEN-ULTRA | methoxsalen | 0187-0650 | FD&C BLUE NO. 1 | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing methoxsalen
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| Actavis Pharma Inc | methoxsalen | 45963-325 | D&C YELLOW NO. 10 |
| Actavis Pharma Inc | methoxsalen | 45963-325 | FD&C BLUE NO. 1 |
| Actavis Pharma Inc | methoxsalen | 45963-325 | FD&C RED NO. 40 |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for methoxsalen
Excipient focus: 1,4-SORBITAN
methoxsalen drug variants containing 1,4-SORBITAN
| Company | Ingredient | NDC |
|---|---|---|
| Bausch Health US LLC | methoxsalen | 0187-0650 |
| >Company | >Ingredient | >NDC |
methoxsalen drug variants not containing 1,4-SORBITAN
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | methoxsalen | 45963-325 |
| Strides Pharma Science Limited | methoxsalen | 64380-752 |
| Oceanside Pharmaceuticals | methoxsalen | 68682-065 |
| >Company | >Ingredient | >NDC |
Excipient focus: AMMONIA
methoxsalen drug variants containing AMMONIA
| Company | Ingredient | NDC |
|---|---|---|
| Strides Pharma Science Limited | methoxsalen | 64380-752 |
| >Company | >Ingredient | >NDC |
methoxsalen drug variants not containing AMMONIA
| Company | Ingredient | NDC |
|---|---|---|
| Bausch Health US LLC | methoxsalen | 0187-0650 |
| Actavis Pharma Inc | methoxsalen | 45963-325 |
| Oceanside Pharmaceuticals | methoxsalen | 68682-065 |
| >Company | >Ingredient | >NDC |
Excipient focus: ANHYDROUS CITRIC ACID
methoxsalen drug variants containing ANHYDROUS CITRIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Strides Pharma Science Limited | methoxsalen | 64380-752 |
| >Company | >Ingredient | >NDC |
methoxsalen drug variants not containing ANHYDROUS CITRIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Bausch Health US LLC | methoxsalen | 0187-0650 |
| Actavis Pharma Inc | methoxsalen | 45963-325 |
| Oceanside Pharmaceuticals | methoxsalen | 68682-065 |
| >Company | >Ingredient | >NDC |
Excipient focus: BUTYL ALCOHOL
methoxsalen drug variants containing BUTYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Strides Pharma Science Limited | methoxsalen | 64380-752 |
| >Company | >Ingredient | >NDC |
methoxsalen drug variants not containing BUTYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Bausch Health US LLC | methoxsalen | 0187-0650 |
| Actavis Pharma Inc | methoxsalen | 45963-325 |
| Oceanside Pharmaceuticals | methoxsalen | 68682-065 |
| >Company | >Ingredient | >NDC |
Excipient focus: D&C YELLOW NO. 10
methoxsalen drug variants containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| Bausch Health US LLC | methoxsalen | 0187-0650 |
| Actavis Pharma Inc | methoxsalen | 45963-325 |
| Strides Pharma Science Limited | methoxsalen | 64380-752 |
| >Company | >Ingredient | >NDC |
methoxsalen drug variants not containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 1
methoxsalen drug variants containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| Bausch Health US LLC | methoxsalen | 0187-0650 |
| Actavis Pharma Inc | methoxsalen | 45963-325 |
| Strides Pharma Science Limited | methoxsalen | 64380-752 |
| >Company | >Ingredient | >NDC |
methoxsalen drug variants not containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C RED NO. 40
methoxsalen drug variants containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | methoxsalen | 45963-325 |
| >Company | >Ingredient | >NDC |
methoxsalen drug variants not containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| Bausch Health US LLC | methoxsalen | 0187-0650 |
| Strides Pharma Science Limited | methoxsalen | 64380-752 |
| Oceanside Pharmaceuticals | methoxsalen | 68682-065 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C YELLOW NO. 6
methoxsalen drug variants containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| Bausch Health US LLC | methoxsalen | 0187-0650 |
| Oceanside Pharmaceuticals | methoxsalen | 68682-065 |
| >Company | >Ingredient | >NDC |
methoxsalen drug variants not containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | methoxsalen | 45963-325 |
| Strides Pharma Science Limited | methoxsalen | 64380-752 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
methoxsalen drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Strides Pharma Science Limited | methoxsalen | 64380-752 |
| >Company | >Ingredient | >NDC |
methoxsalen drug variants not containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Bausch Health US LLC | methoxsalen | 0187-0650 |
| Actavis Pharma Inc | methoxsalen | 45963-325 |
| Oceanside Pharmaceuticals | methoxsalen | 68682-065 |
| >Company | >Ingredient | >NDC |
Excipient focus: GELATIN
methoxsalen drug variants containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | methoxsalen | 45963-325 |
| Strides Pharma Science Limited | methoxsalen | 64380-752 |
| Oceanside Pharmaceuticals | methoxsalen | 68682-065 |
| >Company | >Ingredient | >NDC |
methoxsalen drug variants not containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| Bausch Health US LLC | methoxsalen | 0187-0650 |
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCERIN
methoxsalen drug variants containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| Bausch Health US LLC | methoxsalen | 0187-0650 |
| Actavis Pharma Inc | methoxsalen | 45963-325 |
| Strides Pharma Science Limited | methoxsalen | 64380-752 |
| >Company | >Ingredient | >NDC |
methoxsalen drug variants not containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCINE
methoxsalen drug variants containing GLYCINE
| Company | Ingredient | NDC |
|---|---|---|
| Strides Pharma Science Limited | methoxsalen | 64380-752 |
| >Company | >Ingredient | >NDC |
methoxsalen drug variants not containing GLYCINE
| Company | Ingredient | NDC |
|---|---|---|
| Bausch Health US LLC | methoxsalen | 0187-0650 |
| Actavis Pharma Inc | methoxsalen | 45963-325 |
| Oceanside Pharmaceuticals | methoxsalen | 68682-065 |
| >Company | >Ingredient | >NDC |
Excipient focus: ISOPROPYL ALCOHOL
methoxsalen drug variants containing ISOPROPYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Strides Pharma Science Limited | methoxsalen | 64380-752 |
| >Company | >Ingredient | >NDC |
methoxsalen drug variants not containing ISOPROPYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Bausch Health US LLC | methoxsalen | 0187-0650 |
| Actavis Pharma Inc | methoxsalen | 45963-325 |
| Oceanside Pharmaceuticals | methoxsalen | 68682-065 |
| >Company | >Ingredient | >NDC |
Excipient focus: MEDIUM-CHAIN TRIGLYCERIDES
methoxsalen drug variants containing MEDIUM-CHAIN TRIGLYCERIDES
| Company | Ingredient | NDC |
|---|---|---|
| Strides Pharma Science Limited | methoxsalen | 64380-752 |
| >Company | >Ingredient | >NDC |
methoxsalen drug variants not containing MEDIUM-CHAIN TRIGLYCERIDES
| Company | Ingredient | NDC |
|---|---|---|
| Bausch Health US LLC | methoxsalen | 0187-0650 |
| Actavis Pharma Inc | methoxsalen | 45963-325 |
| Oceanside Pharmaceuticals | methoxsalen | 68682-065 |
| >Company | >Ingredient | >NDC |
Excipient focus: METHYLPARABEN
methoxsalen drug variants containing METHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Bausch Health US LLC | methoxsalen | 0187-0650 |
| Oceanside Pharmaceuticals | methoxsalen | 68682-065 |
| >Company | >Ingredient | >NDC |
methoxsalen drug variants not containing METHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | methoxsalen | 45963-325 |
| Strides Pharma Science Limited | methoxsalen | 64380-752 |
| >Company | >Ingredient | >NDC |
Excipient focus: METHYLPARABEN SODIUM
methoxsalen drug variants containing METHYLPARABEN SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | methoxsalen | 45963-325 |
| >Company | >Ingredient | >NDC |
methoxsalen drug variants not containing METHYLPARABEN SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Bausch Health US LLC | methoxsalen | 0187-0650 |
| Strides Pharma Science Limited | methoxsalen | 64380-752 |
| Oceanside Pharmaceuticals | methoxsalen | 68682-065 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
methoxsalen drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | methoxsalen | 45963-325 |
| >Company | >Ingredient | >NDC |
methoxsalen drug variants not containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Bausch Health US LLC | methoxsalen | 0187-0650 |
| Strides Pharma Science Limited | methoxsalen | 64380-752 |
| Oceanside Pharmaceuticals | methoxsalen | 68682-065 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 400
methoxsalen drug variants containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| Bausch Health US LLC | methoxsalen | 0187-0650 |
| Strides Pharma Science Limited | methoxsalen | 64380-752 |
| Oceanside Pharmaceuticals | methoxsalen | 68682-065 |
| >Company | >Ingredient | >NDC |
methoxsalen drug variants not containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | methoxsalen | 45963-325 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 80
methoxsalen drug variants containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| Strides Pharma Science Limited | methoxsalen | 64380-752 |
| >Company | >Ingredient | >NDC |
methoxsalen drug variants not containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| Bausch Health US LLC | methoxsalen | 0187-0650 |
| Actavis Pharma Inc | methoxsalen | 45963-325 |
| Oceanside Pharmaceuticals | methoxsalen | 68682-065 |
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
methoxsalen drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Strides Pharma Science Limited | methoxsalen | 64380-752 |
| >Company | >Ingredient | >NDC |
methoxsalen drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Bausch Health US LLC | methoxsalen | 0187-0650 |
| Actavis Pharma Inc | methoxsalen | 45963-325 |
| Oceanside Pharmaceuticals | methoxsalen | 68682-065 |
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLPARABEN
methoxsalen drug variants containing PROPYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Bausch Health US LLC | methoxsalen | 0187-0650 |
| Oceanside Pharmaceuticals | methoxsalen | 68682-065 |
| >Company | >Ingredient | >NDC |
methoxsalen drug variants not containing PROPYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | methoxsalen | 45963-325 |
| Strides Pharma Science Limited | methoxsalen | 64380-752 |
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLPARABEN SODIUM
methoxsalen drug variants containing PROPYLPARABEN SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | methoxsalen | 45963-325 |
| >Company | >Ingredient | >NDC |
methoxsalen drug variants not containing PROPYLPARABEN SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Bausch Health US LLC | methoxsalen | 0187-0650 |
| Strides Pharma Science Limited | methoxsalen | 64380-752 |
| Oceanside Pharmaceuticals | methoxsalen | 68682-065 |
| >Company | >Ingredient | >NDC |
Excipient focus: SHELLAC
methoxsalen drug variants containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| Strides Pharma Science Limited | methoxsalen | 64380-752 |
| >Company | >Ingredient | >NDC |
methoxsalen drug variants not containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| Bausch Health US LLC | methoxsalen | 0187-0650 |
| Actavis Pharma Inc | methoxsalen | 45963-325 |
| Oceanside Pharmaceuticals | methoxsalen | 68682-065 |
| >Company | >Ingredient | >NDC |
Excipient focus: SORBITAN
methoxsalen drug variants containing SORBITAN
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | methoxsalen | 45963-325 |
| >Company | >Ingredient | >NDC |
methoxsalen drug variants not containing SORBITAN
| Company | Ingredient | NDC |
|---|---|---|
| Bausch Health US LLC | methoxsalen | 0187-0650 |
| Strides Pharma Science Limited | methoxsalen | 64380-752 |
| Oceanside Pharmaceuticals | methoxsalen | 68682-065 |
| >Company | >Ingredient | >NDC |
Excipient focus: SORBITOL
methoxsalen drug variants containing SORBITOL
| Company | Ingredient | NDC |
|---|---|---|
| Bausch Health US LLC | methoxsalen | 0187-0650 |
| Oceanside Pharmaceuticals | methoxsalen | 68682-065 |
| >Company | >Ingredient | >NDC |
methoxsalen drug variants not containing SORBITOL
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | methoxsalen | 45963-325 |
| Strides Pharma Science Limited | methoxsalen | 64380-752 |
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
methoxsalen drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Bausch Health US LLC | methoxsalen | 0187-0650 |
| Actavis Pharma Inc | methoxsalen | 45963-325 |
| Strides Pharma Science Limited | methoxsalen | 64380-752 |
| >Company | >Ingredient | >NDC |
methoxsalen drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
methoxsalen drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Bausch Health US LLC | methoxsalen | 0187-0650 |
| Actavis Pharma Inc | methoxsalen | 45963-325 |
| Oceanside Pharmaceuticals | methoxsalen | 68682-065 |
| >Company | >Ingredient | >NDC |
methoxsalen drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Strides Pharma Science Limited | methoxsalen | 64380-752 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
